Deadly Psychiatry and Organised DenialDEADLY PSYCHIATRY AND ORGANISED DENIAL explains in evidence-based detail why the way we currently use psychiatric drugs does far more harm than good. Professor, Doctor of Medical Science, Peter C. Gøtzsche documents that psychiatric drugs kill more than half a million people every year among those aged 65 and above in the United States and Europe. This makes psychiatric drugs the third leading cause of death, after heart disease and cancer. Gøtzsche explains that we could reduce our current usage of psychotropic drugs by 98% and at the same time improve patients' mental and physical health and survival. It can be difficult, however, to come off the drugs, as many people become dependent on them. As the withdrawal symptoms can be severe, long-lasting and even dangerous, slow tapering is usually necessary. In his book, Gøtzsche debunks the many myths that leading psychiatrists - very often on drug industry payroll - have created and nurtured over decades in order to conceal the fact that biological psychiatry has generally been a failure. Biological psychiatry sees drugs as the "solution" for virtually all problems, in marked contrast to the patients' views. Most patients don't respond to the drugs they receive but, unfortunately, the psychiatrists' frustrations over the lack of progress often lead to more diagnoses, more drugs and higher doses, harming the patients further. |
Common terms and phrases
accessed ADHD ADHD drugs adults adverse akathisia Alzheimer’s antidepressant drugs antipsychotic drugs anxiety behaviour benzodiazepines bipolar disorder brain damage Breggin cause Chapter chemical imbalance children and adolescents citalopram Cochrane Database Syst Cochrane review controlled trials Danish Database Syst Rev David Healy death dementia diagnosis disease doctors Dorrit dose drug companies drug industry drug treatment duloxetine Eli Lilly evidence FDA’s fluoxetine forced treatment Gøtzsche PC harmful hospital killed Lancet Luise Luise’s Lundbeck medication medicine mental disorders mental health mental illness meta-analysis methylphenidate olanzapine organised outcomes paroxetine person Peter Breggin Pfizer pills placebo placebo group prescribed prescription problems psychiatric drugs psychiatrists psychosis psychotherapy psychotropic drugs published randomised trials reported risk of suicide risperidone schizophrenia selective serotonin reuptake serotonin serotonin reuptake inhibitors sertraline showed side effects silverbacks SSRIs staff stop suicide attempts systematic review therapy told treated withdrawal symptoms